Baby Safety / Compounds / Daidzein

Is Daidzein safe for babies and kids?

Moderate risk for kids

Infants are more vulnerable to Daidzein than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

What is daidzein?

The IUPAC name is 7-hydroxy-3-(4-hydroxyphenyl)chromen-4-one.

Also known as: 4',7-Dihydroxyisoflavone, Daidzeol, 7-hydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one, 7,4'-Dihydroxyisoflavone.

IUPAC name
7-hydroxy-3-(4-hydroxyphenyl)chromen-4-one
CAS number
486-66-8
Molecular formula
C15H10O4
Molecular weight
254.24 g/mol
SMILES
Oc1ccc(-c2coc3cc(O)ccc3c2=O)cc1
PubChem CID
5281708

Risk for babies

Moderate risk

Infants are more vulnerable to Daidzein than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

Neonates and infants up to 12 months have incomplete blood-brain barrier development, immature Phase I/II metabolic enzymes (particularly CYP3A4, UGT1A1), and higher gastrointestinal permeability. Equivalent doses produce higher internal concentrations and longer residence times.

What to do: Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

Risk for pregnant and nursing people

High risk

Pregnancy alters the metabolism and distribution of Daidzein, potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.

Known reproductive toxicant (GHS H360) or confirmed endocrine disruptor. Placental transfer is presumed. Fetal exposure during critical developmental windows may cause structural malformations, growth restriction, or functional deficits.

What to do: Minimize exposure during pregnancy and lactation. Consult healthcare provider regarding specific risks. Consider alternative products with lower hazard profiles.

Regulatory consensus

2 regulatory and scientific bodies have classified Daidzein. The classifications differ — that's the data.

AgencyYearClassificationNotes
FDA1999GRAS as component of soy foods
EFSA2015No safety concern at dietary levels

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where kids encounter daidzein

  • Food
  • Dietary Supplement

Safer alternatives

Lower-risk approaches that achieve a similar outcome to Daidzein:

  • S-equol supplement (direct metabolite)
    Trade-offs: Only 30-50% of Western populations produce equol naturally from daidzein. Direct supplementation bypasses this. Limited clinical data.
    Relative cost: 3-5×

Frequently asked questions

Is daidzein safe for kids?

Infants are more vulnerable to Daidzein than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

What should I do if my child is exposed to daidzein?

Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

See Daidzein in the baby app

Look up products containing daidzein, compare to alternatives, and explore the full data record.

Open in baby View raw API data

Sources (1)

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →